Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 21, 2011 (rev. 1)

Premium

Epigenomics this week announced the appointment of Noel Doheny as CEO of the company's US subsidiary in Seattle.

Doheny will report to Geert Nygaard, CEO of Epigenomics AG, and will start in his new position in early May.

Doheny most recently served as CEO of OpGen from 2008 to 2009. Prior to this, he held positions as senior vice president for the molecular diagnostics division of Affymetrix; vice president of pre-analytical solutions and a member of the executive committee at Qiagen; and president and CEO of BioStar (now ThermoBioStar).

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.